Philips North America has been the subject of 355 FDA enforcement/approval records tracked by Argus HQ, compared to 1 for HealthPartners Neuroscience Center Research and Innovation.
HealthPartners Neuroscience Center Research and Innovation: 1 warning letter, 0 recalls, 0 approval records, 0 Form 483s.
Philips North America: 0 warning letters, 355 recalls, 0 approval records, 0 Form 483s.
Side by side
HealthPartners Neuroscience Center Research and Innovation — Warning letters1
Philips North America — Warning letters0
HealthPartners Neuroscience Center Research and Innovation — Recalls0
Philips North America — Recalls355
HealthPartners Neuroscience Center Research and Innovation — Approval records0
Philips North America — Approval records0
HealthPartners Neuroscience Center Research and Innovation — Form 483s0
Philips North America — Form 483s0
Timeline
HealthPartners Neuroscience Center Research and Innovation
Most recent FDA action: May 19, 2026
Full history →Cite this comparison
Pre-formatted for a story, footnote, or reference list:
"HealthPartners Neuroscience Center Research and Innovation vs Philips North America: FDA Enforcement Comparison." Argus HQ, accessed August 29, 2026. https://argushq.ai/compare/healthpartners-neuroscience-center-research-and-innovation-vs-philips-north-america
Source: FDA.gov (aggregated across Warning Letters, Recalls, Approvals, Form 483s) ↗